ctDNA blood test for treatment response in small cell lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study looks at a blood test called ctDNA to help doctors see how well treatment is working and to predict what might happen in patients with extensive stage small cell lung cancer. Participation involves regular blood draws and follow-ups, which might help guide your cancer care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been newly diagnosed with extensive stage small cell lung cancer.
- The diagnosis is confirmed by a biopsy or other cell sample test.
- Your health is stable enough to receive chemotherapy and radiation therapy.
- You are willing to provide blood samples and clinic data for the study.
- You can commit to follow-up visits according to the study schedule.
- You do not have any other active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a simple blood test (called ctDNA-MRD) can help guide treatment for people with advanced lung cancer that has not spread far. You would receive chemotherapy plus immunotherapy before surgery, and the blood test may help doctors understand how well the treatment is working.
This study checks whether a special blood test (ctDNA) taken before and after surgery can predict whether non-small cell lung cancer will come back. If it works, it may help doctors spot recurrence earlier and guide follow-up care after tumor removal.
This study uses a blood test called ctDNA to look for leftover lung cancer after surgery. Based on that result, the trial will help decide which treatment approach is best for you and may catch cancer returning earlier.
This trial collects blood and tumor samples from people newly diagnosed with small cell lung cancer to study how genetic markers can predict treatment success and monitor disease over time.
This observational study collects information and lab samples from people with extensive-stage small cell lung cancer. It may help researchers understand how patients respond and improve future care, but it usually does not add new treatment for you.
This trial checks whether a blood test that looks for cancer DNA can help guide and monitor treatment in people with advanced non-small cell lung cancer (NSCLC). It may help your team spot treatment response or changes earlier, so care can be adjusted appropriately.
Hear when a new Small Cell Lung Cancer Extensive Stage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.